H2BC21 and leishmaniasis: Nervertheless, we have previously reported that Leishmania H2B [49], L. amazonensis PSA protein (LaPSA-38S) [47] and LmlRAB [48], were able to induce a dominant Th1 profile of immune response in cured CL individuals, suggesting that these proteins are potential vaccine candidates against human leishmaniasis.